Matinas BioPharma Holdings, Inc. is a biopharmaceutical company based in Bedminster Twp, NJ, specializing in the development of innovative therapeutics. Their Lipid Nano-Crystal (LNC) platform allows for safe and effective intracellular delivery of a wide range of drug therapies, including small molecules, nucleic acid polymers, proteins, and vaccines. With their LNC technology, they have successfully developed MAT2203 and MAT2501, two powerful treatments targeting life-threatening fungal and bacterial infections.
Matinas BioPharma Holdings, Inc. has demonstrated in vivo biological activity and disease improvement in two inflammatory disease models using their oral LNC-delivered small oligonucleotides. They provide regular updates on their regulatory and development pathway, ensuring transparency and compliance with FDA guidelines. With a dedicated team and a focus on scientific advancements, Matinas BioPharma Holdings, Inc. is committed to improving patient outcomes through their innovative LNC platform.
Generated from the website